• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由RNA干扰或异染色质驱动的表观突变引发人类真菌病原体的抗真菌药物耐药性。

Epimutations driven by RNAi or heterochromatin evoke antifungal drug resistance in human fungal pathogens.

作者信息

Son Ye-Eun, Heitman Joseph

机构信息

Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA.

出版信息

bioRxiv. 2025 Jul 11:2025.06.17.660219. doi: 10.1101/2025.06.17.660219.

DOI:10.1101/2025.06.17.660219
PMID:40631117
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12236829/
Abstract

Antimicrobial resistance is a global health threat emerging through microbe adaptation, driven by genetic variation, genome plasticity or epigenetic regulation. This study investigates how the species complex adapts to the antifungal natural product FK506. In , most resistant strains exhibit unstable phenotypes without genetic changes. Approximately ~50% of FK506-resistant isolates acquire resistance via RNAi-dependent epimutation, where small interfering RNAs (siRNAs) silence transcription. The remaining isolates undergo heterochromatin-mediated silencing via H3K9 methylation and siRNAs spreading, repressing and neighboring genes. One isolate retained only heterochromatin marks without detectable siRNAs. A similar mechanism operates in , where FK506 resistance is mediated by ectopic heterochromatin associated with siRNA. Strikingly, heterochromatin-based epimutation inheritance remains stable following infection. These findings reveal that antifungal resistance can arise through distinct, heritable epigenetic pathways involving RNAi, heterochromatin, or both highlighting adaptive strategies employed by ubiquitous eukaryotic microbial pathogens infecting humans.

摘要

抗菌耐药性是一种全球健康威胁,它通过微生物适应而出现,由基因变异、基因组可塑性或表观遗传调控驱动。本研究调查了该物种复合体如何适应抗真菌天然产物FK506。在 中,大多数耐药菌株表现出不稳定的表型且无基因变化。约50%的FK506耐药分离株通过RNAi依赖的表观突变获得耐药性,其中小干扰RNA(siRNAs)使 转录沉默。其余分离株通过H3K9甲基化和siRNAs扩散进行异染色质介导的沉默,抑制 和邻近基因。一个分离株仅保留了异染色质标记而未检测到siRNAs。在 中存在类似机制,其中FK506耐药性由与siRNA相关的异位异染色质介导。引人注目的是,基于异染色质的表观突变遗传在 感染后仍保持稳定。这些发现揭示了抗真菌耐药性可通过涉及RNAi、异染色质或两者的不同可遗传表观遗传途径产生,突出了感染人类的普遍存在的真核微生物病原体所采用的适应性策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea8/12261884/2bbfbb4632d9/nihpp-2025.06.17.660219v3-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea8/12261884/d9f322e880d1/nihpp-2025.06.17.660219v3-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea8/12261884/b17ee084ef0f/nihpp-2025.06.17.660219v3-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea8/12261884/4841416b0325/nihpp-2025.06.17.660219v3-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea8/12261884/cf8b998efa92/nihpp-2025.06.17.660219v3-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea8/12261884/ce14ab87d981/nihpp-2025.06.17.660219v3-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea8/12261884/5b5a389e477c/nihpp-2025.06.17.660219v3-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea8/12261884/2bbfbb4632d9/nihpp-2025.06.17.660219v3-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea8/12261884/d9f322e880d1/nihpp-2025.06.17.660219v3-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea8/12261884/b17ee084ef0f/nihpp-2025.06.17.660219v3-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea8/12261884/4841416b0325/nihpp-2025.06.17.660219v3-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea8/12261884/cf8b998efa92/nihpp-2025.06.17.660219v3-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea8/12261884/ce14ab87d981/nihpp-2025.06.17.660219v3-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea8/12261884/5b5a389e477c/nihpp-2025.06.17.660219v3-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea8/12261884/2bbfbb4632d9/nihpp-2025.06.17.660219v3-f0007.jpg

相似文献

1
Epimutations driven by RNAi or heterochromatin evoke antifungal drug resistance in human fungal pathogens.由RNA干扰或异染色质驱动的表观突变引发人类真菌病原体的抗真菌药物耐药性。
bioRxiv. 2025 Jul 11:2025.06.17.660219. doi: 10.1101/2025.06.17.660219.
2
Antifungal drug resistance evoked via RNAi-dependent epimutations.通过 RNAi 依赖性表观遗传突变引发的抗真菌药物耐药性。
Nature. 2014 Sep 25;513(7519):555-8. doi: 10.1038/nature13575. Epub 2014 Jul 27.
3
Drug-Resistant Epimutants Exhibit Organ-Specific Stability and Induction during Murine Infections Caused by the Human Fungal Pathogen Mucor circinelloides.耐药性 Epimutants 在人类真菌病原体环孢菌引起的小鼠感染中表现出器官特异性稳定性和诱导。
mBio. 2019 Nov 5;10(6):e02579-19. doi: 10.1128/mBio.02579-19.
4
RNAi epimutations conferring antifungal drug resistance are inheritable.赋予抗真菌药物抗性的RNA干扰表观突变是可遗传的。
Nat Commun. 2025 Aug 7;16(1):7293. doi: 10.1038/s41467-025-62572-6.
5
RNAi epimutations conferring antifungal drug resistance are inheritable.赋予抗真菌药物抗性的RNA干扰表观突变是可遗传的。
bioRxiv. 2025 Jun 4:2024.10.15.618540. doi: 10.1101/2024.10.15.618540.
6
Broad antifungal resistance mediated by RNAi-dependent epimutation in the basal human fungal pathogen Mucor circinelloides.RNAi 依赖性表突变介导的基础人类真菌病原体毛霉中环体的广谱抗真菌耐药性。
PLoS Genet. 2019 Feb 11;15(2):e1007957. doi: 10.1371/journal.pgen.1007957. eCollection 2019 Feb.
7
A non-canonical RNA degradation pathway suppresses RNAi-dependent epimutations in the human fungal pathogen Mucor circinelloides.一条非经典RNA降解途径抑制人类真菌病原体卷枝毛霉中RNA干扰依赖的表观突变。
PLoS Genet. 2017 Mar 24;13(3):e1006686. doi: 10.1371/journal.pgen.1006686. eCollection 2017 Mar.
8
Unveiling antifungal resistance and biocide tolerance in clinical isolates of spp.揭示 spp. 临床分离株中的抗真菌耐药性和对杀菌剂的耐受性
Future Microbiol. 2025 Apr;20(6):457-468. doi: 10.1080/17460913.2025.2480924. Epub 2025 Mar 22.
9
T-bet expressing Tr1 cells driven by dietary signals dominate the small intestinal immune landscape.由饮食信号驱动的表达T-bet的Tr1细胞主导小肠免疫格局。
bioRxiv. 2025 Jul 4:2025.06.30.662190. doi: 10.1101/2025.06.30.662190.
10
Distinct adaptation and epidemiological success of different genotypes within serovar Dublin.都柏林血清型内不同基因型的独特适应性和流行病学成功情况。
Elife. 2025 Jun 25;13:RP102253. doi: 10.7554/eLife.102253.

本文引用的文献

1
RNAi epimutations conferring antifungal drug resistance are inheritable.赋予抗真菌药物抗性的RNA干扰表观突变是可遗传的。
Nat Commun. 2025 Aug 7;16(1):7293. doi: 10.1038/s41467-025-62572-6.
2
Fungal impacts on Earth's ecosystems.真菌对地球生态系统的影响。
Nature. 2025 Feb;638(8049):49-57. doi: 10.1038/s41586-024-08419-4. Epub 2025 Feb 5.
3
A one health roadmap towards understanding and mitigating emerging Fungal Antimicrobial Resistance: fAMR.一份关于理解和减轻新出现的真菌抗菌药物耐药性(fAMR)的“同一健康”路线图。
NPJ Antimicrob Resist. 2024;2(1):36. doi: 10.1038/s44259-024-00055-2. Epub 2024 Nov 7.
4
Molecular mechanisms governing antifungal drug resistance.抗真菌药物耐药性的分子机制。
NPJ Antimicrob Resist. 2023;1(1):5. doi: 10.1038/s44259-023-00007-2. Epub 2023 Jul 17.
5
Molecular mechanisms that govern infection and antifungal resistance in Mucorales.控制毛霉目真菌感染和抗真菌耐药性的分子机制。
Microbiol Mol Biol Rev. 2024 Mar 27;88(1):e0018822. doi: 10.1128/mmbr.00188-22. Epub 2024 Mar 6.
6
Global incidence and mortality of severe fungal disease.严重真菌病的全球发病率和死亡率。
Lancet Infect Dis. 2024 May;24(5):e268. doi: 10.1016/S1473-3099(24)00102-6. Epub 2024 Feb 20.
7
The novel spore-specific regulator SscA controls conidiogenesis.新型孢子特异性调控因子 SscA 控制分生孢子的形成。
mBio. 2023 Oct 31;14(5):e0184023. doi: 10.1128/mbio.01840-23. Epub 2023 Sep 14.
8
The rapid emergence of antifungal-resistant human-pathogenic fungi.抗真菌药物耐药性人类致病真菌的迅速出现。
Nat Rev Microbiol. 2023 Dec;21(12):818-832. doi: 10.1038/s41579-023-00960-9. Epub 2023 Aug 30.
9
The WHO fungal priority pathogens list as a game-changer.世界卫生组织真菌优先病原体清单——改变游戏规则的因素。
Nat Rev Microbiol. 2023 Apr;21(4):211-212. doi: 10.1038/s41579-023-00861-x.
10
Heterochromatin and RNAi act independently to ensure genome stability in Mucorales human fungal pathogens.异染色质和 RNAi 独立作用以确保毛霉目人类真菌病原体的基因组稳定性。
Proc Natl Acad Sci U S A. 2023 Feb 14;120(7):e2220475120. doi: 10.1073/pnas.2220475120. Epub 2023 Feb 6.